Kintara Therapeutics Q3 EPS $(0.11) Up From $(0.23) YoY
Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.11) per share. This is a 52.17 percent increase over losses of $(0.23) per share from the same period last year.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
83 Biggest Movers From Yesterday
Gainers
Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers
Zosano Pharma (NASDAQ:ZSAN) shares rose 3127.9% to $3.88 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.0 million.
Kintara Therapeutics Says ‘For all three transporters VAL-083 was not a substrate for these active transport systems. This suggests that VAL-083 may be crossing the BBB by passive diffusion rather than facilitated active transport.’
VAL-083 shares structural and molecular similarities to glucose including low molecular weight and high water solubility. Glucose transporters, in particular GLUT1, are overexpressed by the BBB since the brain requires